ADDNOK
2MG SLG TBL NOB 14
| SÚKL code | 0152096 |
|---|---|
| Name of the product | ADDNOK |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | ADDNOK |
| Supplement | 2MG SLG TBL NOB 14 |
| Strenght | 2MG |
| Pharmaceutical form | Sublingual tablet |
| Package | 14 |
| Route | Sublingual use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance | BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINI HYDROCHLORIDUM) |
| ATC group | N07BC01 |
| ATC group name | BUPRENORFIN |
| Doping | Narkotika (zakázané pouze při soutěži). Bližší informace viz www.antidoping.cz/cs/zakazane-leky |
Marketing authorisation information
| Registration Number | 19/ 697/10-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Reference member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 29. 02. 2020 |
| MA Holder | Activase Pharmaceuticals Ltd., Nicosia |
| MA Holder country | KYPR |
| Actual MA holder | I-GEN, LDA, Caparica |
| Actual MA holder country | PORTUGALSKO |
cz